Related Experiment Videos
[Pathogenetic factors in thrombosis of the central retinal vein]
Insights
Central retinal vein (CRV) thrombosis is linked to poor blood flow, clotting changes, and impaired circulation. Treatments targeting blood rheology are recommended for CRV thrombosis management.
Area of Science:
- Ophthalmology
- Hematology
- Vascular Biology
Background:
- Central retinal vein (CRV) thrombosis is a significant cause of vision loss.
- Understanding the underlying hemorheologic and hemostatic factors is crucial for effective management.
Purpose of the Study:
- To investigate the hemorheologic parameters and hemostasis system in patients with CRV thrombosis.
- To identify key factors contributing to the pathogenesis of CRV thrombosis.
Main Methods:
- Analysis of blood and lacrimal fluid from 130 patients with CRV thrombosis.
- Assessment of hemorheologic parameters and hemostasis system components.
- Calibrometry of the central retinal vein (CRV).
Main Results:
- Disordered blood rheology was identified as a major factor in CRV thrombosis.
- Alterations in the local hemostatic potential were observed.
- Impaired blood stream in CRV branches was a significant finding.
Conclusions:
- The pathogenesis of CRV thrombosis involves a combination of rheologic, hemostatic, and hemodynamic factors.
- Normalization of blood rheology is a rational therapeutic strategy for CRV thrombosis.
Abstract:
Studies of the hemorheologic parameters and the hemostasis system components in the blood and lacrimal fluid of 130 patients with thrombosis of a branch of the central retinal vein (CRV) and calibrometry of the CRV have lead the authors to a conclusion that the major factors contributing to the pathogenesis of CRV thrombosis are (1) disordered blood rheology; (2) changes in the local hemostatic potential; (3) impaired blood stream in the corresponding CRV branches. Rationale for the use of drugs normalizing the blood rheology in CRV thrombosis is given.